Trial intelligence / Profile preview

Lidocaine/Prilocaine Topical Anesthetic for CO2 Fractional Laser Treatment

NCT03366246Phase 3Completed

Sponsor
Galeno Research Center
Start
Jun 2014
Primary completion
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of lidocaine 10% oropharyngeal spray and prilocaine in pain (2 arms), sponsored by Galeno Research Center. Primary endpoint: Pain assessed by means of a visual analog scale at 90 minutes. Started Jun 2014; status: completed.

02

Drugs

lidocaine 10% oropharyngeal sprayprilocaine
03

Conditions

pain

Beyond the preview

Go deeper on NCT03366246.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03366246.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call